Increased amoeboid microglial density in the Olfactory Bulb of Parkinson's and Alzheimer's Patients

Brain Pathology

Volumn 24, Issue 2, 2014, Pages 152-165

  Doorn, Karlijn J ^a,b   Goudriaan, Andrea ^b,c   Blits Huizinga, Carla ^b   Bol, John G J M ^b   Rozemuller, Annemieke J ^b   Hoogland, Piet V J M ^b   Lucassen, Paul J ^a   Drukarch, Benjamin ^b   Van De Berg, Wilma D J ^b   Van Dam, Anne Marie ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

synuclein; amyloid; Alzheimer's disease; anterior olfactory nucleus; hyperphosphorylated tau; microglia; neuroinflammation; olfactory bulb; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; CELL COUNT; FEMALE; HUMAN; MALE; METABOLISM; MICROGLIA; MIDDLE AGED; NERVE CELL; OLFACTORY BULB; PARKINSON DISEASE; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CELL COUNT; FEMALE; HUMANS; MALE; MICROGLIA; MIDDLE AGED; NEURONS; OLFACTORY BULB; PARKINSON DISEASE; TAU PROTEINS;

EID: 84894268777     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12088     Document Type: Article

References (85)

1. Akiyama H, Schwab C, Kondo H, Mori H, Kametani F, Ikeda K, McGeer PL, (1996) Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of β-amyloid protein. Neurosci Lett 206: 169-172.
2. Attems J, Lintner F, Jellinger KA, (2005) Olfactory involvement in aging and Alzheimer's disease: an autopsy study. J Alzheimers Dis 7: 149-158.
3. Berendse HW, Roos DS, Raijmakers P, Doty RL, (2011) Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease. J Neurol Sci 310: 21-24.
4. Block ML, Hong JS, (2005) Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 76: 77-98.
5. Bodian D, (1936) A new method for staining nerve fibers and nerve endings in mounted paraffin sections. Anat Rec 65: 89-97.
6. Braak H, Braak E, (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 82: 239-259.
7. Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rüb U, (2002) Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol 249: 1-5.
8. Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E, (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24: 197-211.
9. Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K, (2004) Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318: 121-134.
10. Braak H, Rüb U, Schultz C, Del Tredici K, (2006) Vulnerability of cortical neurons to Alzheimer's and Parkinson's diseases. J Alzheimers Dis 9: 35-44.
11. Brunjes PC, Illig KR, Meyer EA, (2005) A field guide to the anterior olfactory nucleus (cortex). Brain Res Rev 50: 305-335.
12. Croisier E, Moran LB, Dexter DT, Pearce RKB, Graeber MB, (2005) Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition. J Neuroinflammation 2: 14-22.
13. Crowther RA, (1993) Tau protein and paired helical filaments of Alzheimer's disease. Curr Opin Struct Biol 3: 202-206.
14. Curtis MA, Kam M, Nannmark U, Anderson MF, Axell MZ, Wikkelso C, et al (2007) Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension. Science 315: 1243-1249.
15. Devanand DP, Michaels-Marston KS, Liu X, Pelton GH, Padilla M, Marder K, et al (2000) Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry 157: 1399-1405.
16. DiPatre PL, Gelman BB, (1997) Microglial cell activation in aging and Alzheimer disease: partial linkage with neurofibrillary tangle burden in the hippocampus. J Neuropathol Exp Neurol 56: 143-149.
17. Dodel RC, Lohmüller F, Du Y, Eastwood B, Gocke P, Oertel WH, Gasser T, (2001) A polymorphism in the intronic region of the IL-1alpha gene and the risk for Parkinson's disease. Neurology 56: 982-983.
18. Doorn KJ, Lucassen PJ, Boddeke HW, Prins M, Berendse HW, Drukarch B, Van Dam AM, (2012) Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease. Prog Neurobiol 98: 222-238.
19. Doty RL, Hawkes CH, Berendse HW, (2011) Olfactory dysfunction in Parkinson's disease and related disorders. In: Non-Dopamine Lesions in Parkinson's Disease, GM Halliday, RA Barker, DB Rowe, (eds), pp. 65-91. Oxford University Press Inc., New York.
20. Familian A, Eikelenboom P, Veerhuis R, (2007) Minocycline does not affect amyloid-β phagocytosis by human microglial cells. Neurosci Lett 416: 87-91.
21. Fiala M, Liu PT, Espinosa-Jeffrey A, Rosenthal MJ, Bernard G, Ringman JM, et al (2007) Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Proc Natl Acad Sci USA 104: 12849-12854.
22. Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M, Hammers A, et al (2006) In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiol Dis 21: 404-412.
23. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH, (2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140: 918-934.
24. Graeber MB, Streit WJ, (2010) Microglia: biology and pathology. Acta Neuropathol (Berl) 119: 89-105.
25. Gregory GE, Greenway AR, Lord KA, (1980) Alcoholic Bouin fixation of insect nervous systems for Bodian silver staining. I,II,III. Biotechnic & Histochemistry 55: 143-165.
26. Grimaldi LME, Casadei VM, Ferri C, Veglia F, Licastro F, Annoni G, et al (2000) Association of early onset Alzheimer's disease with an interleukin(-alpha gene polymorphism. Ann Neurol 47: 361-365.
27. Haehner A, Hummel T, Reichmann H, (2011) Olfactory loss in Parkinson's disease. Park Dis Article ID 450939.
28. Hansen C, Angot E, Bergström AL, Steiner JA, Pieri L, Paul G, et al (2011) Alpha-synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J Clin Invest 121: 715-725.
29. Hashioka S, Miklossy J, Schwab C, Klegeris A, McGeer PL, (2008) Adhesion of exogenous human microglia and THP-1 cells to amyloid plaques of postmortem Alzheimer's disease brain. J Alzheimers Dis 14: 345-352.
30. Hirsch EC, Vyas S, Hunot S, (2012) Neuroinflammation in Parkinson's disease. Parkinsonism Relat Disord 18: 210-212.
31. 142 by human microglia. International J Alzheimers Dis Article ID 798424.
32. Holness CL, Simmons DL, (1993) Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 81: 1607-1613.
33. Huisman E, Uylings H, Hoogland PV, (2004) A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease. Mov Disord 19: 687-692.
34. Imamura K, Hishikawa N, Sawada M, Nagatsu T, Yoshida M, Hashizume Y, (2003) Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains. Acta Neuropathol (Berl) 106: 518-526.
35. Irwin DJ, White MT, Toledo JB, Xie SX, Robinson JL, Deerlin VV, et al (2012) Neuropathologic substrates of Parkinson's disease dementia. Ann Neurol 72: 587-598.
36. Koenigsknecht J, Landreth G, (2004) Microglial phagocytosis of fibrillar β-amyloid through a 1 integrin-dependent mechanism. J Neurosci 24: 9838-9846.
37. Kovacs T, Cairns NJ, Lantos PL, (1999) beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease. Neuropathol Appl Neurobiol 25: 481-491.
38. Kreutzberg GW, (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19: 312-318.
39. Kuhn HG, Palmer TD, Fuchs E, (2001) Adult neurogenesis: a compensatory mechanism for neuronal damage. Eur Arch Psychiatry Clin Neurosci 251: 152-158.
40. Lai AY, McLaurin JA, (2012) Clearance of amyloid-β peptides by microglia and macrophages: the issue of what, when and where. Future Neurol 7: 165-176.
41. Lavelle A, (1956) Nucleolar and Nissl substance development in nerve cells. J Comp Neurol 104: 175-205.
42. Lee HJ, Patel S, Lee SJ, (2005) Intravesicular localization and exocytosis of α-synuclein and its aggregates. J Neurosci 25: 6016-6024.
43. Lei H, Mooney R, Katz LC, (2006) Synaptic integration of olfactory information in mouse anterior olfactory nucleus. J Neurosci 26: 12023-12032.
44. Lööv C, Hillered L, Ebendal T, Erlandsson A, (2012) Engulfing astrocytes protect neurons from contact-induced apoptosis following injury. PLoS One 7: e33090.
45. Luk KC, Kehm V, Carroll J, Zhang B, O'Brien P, Trojanowski JQ, Lee VMY, (2012) Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338: 949-953.
46. Marlatt MW, Lucassen PJ, (2010) Neurogenesis and Alzheimer's disease: biology and pathophysiology in mice and men. Curr Alzheimer Res 7: 113-125.
47. McGeer PL, Itagaki S, Boyes BE, McGeer EG, (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38: 1285-1286.
48. Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M, Nagatsu T, (1994) Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett 180: 147-150.
49. Mucke L, Selkoe DJ, (2012) Neurotoxicity of amyloid β protein: synaptic and network dysfunction. Cold Spring Harb Perspect Med 2: a006338.
50. Mundiñano IC, Caballero MC, Ordõñez C, Hernandez M, DiCaudo C, Marcilla I, et al (2011) Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders. Acta Neuropathol (Berl) 122: 61-74.
51. Murphy C, Gilmore MM, Seery CS, Salmon DP, Lasker BR, (1990) Olfactory thresholds are associated with degree of dementia in Alzheimer's disease. Neurobiol Aging 11: 465-469.
52. Njie MG, Boelen E, Stassen FR, Steinbusch HWM, Borchelt DR, Streit WJ, (2010) Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function. Neurobiol Aging 33: 195.1-195.12.
53. Oide T, Kinoshita T, Arima K, (2006) Regression stage senile plaques in the natural course of Alzheimer's disease. Neuropathol Appl Neurobiol 32: 539-556.
54. Ouchi Y, Yagi S, Yokokura M, Sakamoto M, (2009) Neuroinflammation in the living brain of Parkinson's disease. Parkinsonism Relat Disord 15: 200-204.
55. Overmyer M, Helisalmi S, Soininen H, Laakso M, Riekkinen P Sr, Alafuzoff I, (1999) Reactive microglia in aging and dementia: an immunohistochemical study of postmortem human brain tissue. Acta Neuropathol (Berl) 97: 383-392.
56. Palop JJ, Chin J, Mucke L, (2006) A network dysfunction perspective on neurodegenerative diseases. Nature 443: 768-773.
57. Park JY, Paik SR, Jou I, Park SM, (2008) Microglial phagocytosis is enhanced by monomeric α-synuclein, not aggregated α-synuclein: implications for Parkinson's disease. Glia 56: 1215-1223.
58. Perlmutter LS, Scott SA, Barron E, Chui HC, (1992) MHC class II positive microglia in human brain: association with Alzheimer lesions. J Neurosci Res 33: 549-558.
59. Pletnikova O, West N, Lee MK, Rudow GL, Skolasky RL, Dawson TM, et al (2005) Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases. Neurobiol Aging 26: 1183-1192.
60. Ponsen MM, Stoffers D, Booij J, van Eck Smit BLF, Wolters EC, Berendse HW, (2004) Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 56: 173-181.
61. Price JL, (1990) Olfactory system. In: The Human Nervous System., G Paxinos, JK Mai, (eds.), pp. 979-998. Academic Press: San Diego.
62. Reynolds AD, Glanzer JG, Kadiu I, Ricardo Dukelow M, Chaudhuri A, Ciborowski P, et al (2008) Nitrated alpha synuclein activated microglial profiling for Parkinson's disease. J Neurochem 104: 1504-1525.
63. Saiz-Sanchez D, Ubeda-Banon I, de la Rosa-Prieto C, Argandona-Palacios L, Garcia-Munozguren S, Insausti R, Martinez-Marcos A, (2010) Somatostatin, tau, and β-amyloid within the anterior olfactory nucleus in Alzheimer disease. Exp Neurol 223: 347-350.
64. Sasaki A, Kawarabayashi T, Murakami T, Matsubara E, Ikeda M, Hagiwara H, et al (2008) Microglial activation in brain lesions with tau deposits: comparison of human tauopathies and tau transgenic mice TgTauP301L. Brain Res 1214: 159-168.
65. Selkoe DJ, (1991) The molecular pathology of Alzheimer's disease. Neuron 6: 487-498.
66. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M, (1998) Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95: 6469-6473.
67. Stalder M, Deller T, Staufenbiel M, Jucker M, (2001) 3D-Reconstruction of microglia and amyloid in APP23 transgenic mice: no evidence of intracellular amyloid. Neurobiol Aging 22: 427-434.
68. Streit WJ, Sammons NW, Kuhns AJ, Sparks DL, (2004) Dystrophic microglia in the aging human brain. Glia 45: 208-212.
69. Streit WJ, Braak H, Xue QS, Bechmann I, (2009) Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta Neuropathol (Berl) 118: 475-485.
70. Strohmeyer R, Kovelowski C, Mastroeni D, Leonard B, Grover A, Rogers J, (2005) Microglial responses to amyloid β peptide opsonization and indomethacin treatment. J Neuroinflammation 2: 18-29.
71. Su X, Maguire-Zeiss KA, Giuliano R, Prifti L, Venkatesh K, Federoff HJ, (2008) Synuclein activates microglia in a model of Parkinson's disease. Neurobiol Aging 29: 1690-1701.
72. Su X, Federoff HJ, Maguire-Zeiss KA, (2009) Mutant alpha-synuclein overexpression mediates early proinflammatory activity. Neurotox Res 16: 238-254.
73. Tan J, Town T, Paris D, Mori T, Suo Z, Crawford F, et al (1999) Microglial activation resulting from CD40-CD40L interaction after β-amyloid stimulation. Science 286: 2352-2355.
74. Thal DR, Schultz C, Dehghani F, Yamaguchi H, Braak H, Braak E, (2000) Amyloid β-protein (A+β)-containing astrocytes are located preferentially near N-terminal-truncated A+β deposits in the human entorhinal cortex. Acta Neuropathol (Berl) 100: 608-617.
75. Tsuboi Y, Wszolek ZK, Graff-Radford NR, Cookson N, Dickson DW, (2003) Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein ε4. Neuropathol Appl Neurobiol 29: 503-510.
76. van den Berge SA, van Strien ME, Korecka JA, Dijkstra AA, Sluijs JA, Kooijman L, et al (2011) The proliferative capacity of the subventricular zone is maintained in the parkinsonian brain. Brain 134: 3249-3263.
77. Van Everbroeck B, Dobbeleir I, De Waele M, De Leenheir E, Lübke U, Martin JJ, Cras P, (2004) Extracellular protein deposition correlates with glial activation and oxidative stress in Creutzfeldt-Jakob and Alzheimer's disease. Acta Neuropathol (Berl) 108: 194-200.
78. Versijpt JJ, Dumont F, Van Laere KJ, Decoo D, Santens P, Audenaert K, et al (2003) Assessment of neuroinflammation and microglial activation in Alzheimer's disease with radiolabelled PK11195 and single photon emission computed tomography. Eur Neurol 50: 39-47.
79. Vilhardt F, (2005) Microglia: phagocyte and glia cell. Int J Biochem Cell Biol 37: 17-21.
80. Vroon A, Drukarch B, Bol JGJM, Cras P, Brevé JJP, Allan SM, et al (2007) Neuroinflammation in Parkinson's patients and MPTP-treated mice is not restricted to the nigrostriatal system: microgliosis and differential expression of interleukin-1 receptors in the olfactory bulb. Exp Gerontol 42: 762-771.
81. Walter L, Neumann H, (2009) Role of microglia in neuronal degeneration and regeneration. Semin Immunopathol 31: 513-525.
82. Watson MB, Richter F, Lee SK, Gabby L, Wu J, Masliah E, et al (2012) Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein. Exp Neurol 237: 318-334.
83. West MJ, Slomianka L, Gundersen HJG, (1991) Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 231: 482-497.
84. Wyss-Coray T, Loike JD, Brionne TC, Lu E, Anankov R, Yan F, et al (2003) Adult mouse astrocytes degrade amyloid-β in vitro and in situ. Nat Med 9: 453-457.
85. Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML, et al (2005) Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J 19: 533-542.